Advertisement
Research Article| Volume 22, ISSUE 9, P1137-1150, September 1987

Postdexamethasone plasma cortisol and β-endorphin levels in depression: Relationship to severity of illness

  • James H. Meador-Woodruff
    Correspondence
    Address reprint requests to Dr. James H. Meador-Woodruff, Department of Psychiatry, Mental Health Research Institute, University of Michigan Medical Center, 205 Washtenaw Place, Ann Arbor, MI 48109-0720.
    Affiliations
    From the Clinical Studies Unit for Affective Disorders and the Mental Health Research Institute, Department of Psychiatry, University of Michigan, Ann Arbor, MIU.S.A.
    Search for articles by this author
  • Roger F. Haskett
    Affiliations
    From the Clinical Studies Unit for Affective Disorders and the Mental Health Research Institute, Department of Psychiatry, University of Michigan, Ann Arbor, MIU.S.A.
    Search for articles by this author
  • Leon Grunhaus
    Affiliations
    From the Clinical Studies Unit for Affective Disorders and the Mental Health Research Institute, Department of Psychiatry, University of Michigan, Ann Arbor, MIU.S.A.
    Search for articles by this author
  • Huda Akil
    Affiliations
    From the Clinical Studies Unit for Affective Disorders and the Mental Health Research Institute, Department of Psychiatry, University of Michigan, Ann Arbor, MIU.S.A.
    Search for articles by this author
  • Stanley J. Watson
    Affiliations
    From the Clinical Studies Unit for Affective Disorders and the Mental Health Research Institute, Department of Psychiatry, University of Michigan, Ann Arbor, MIU.S.A.
    Search for articles by this author
  • John F. Greden
    Affiliations
    From the Clinical Studies Unit for Affective Disorders and the Mental Health Research Institute, Department of Psychiatry, University of Michigan, Ann Arbor, MIU.S.A.
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The hypothalamic-pituitary-adrenal (HPA) axis is dysregulated in many patients with depression, probably at all levels of the axis. To determine if HPA dysregulation is associated with severity of depression, we studied a group of 66 patients with major depressive disorder. Each patient underwent a pretreatment Dexamethasone Suppression Test, with plasma postdexamethasone cortisol determination at 8:00 AM, 4:00 PM, and 11:00 PM. All three postdexamethasone cortisol levels were significantly correlated with the Hamilton Rating Scale for Depression (HRSD) scores. We also examined the “profile” measures of mean, maximum, and minimum of the three cortisol values; again, all three were significantly correlated with HRSD scores. To evaluate associations between clinical severity and HPA dysregulation at the pituitary level, we studied a second group of 44 patients with major depressive disorder. Each had postdexamethasone cortisol determinations at 4:00 PM and 11:00 PM as well as pre- and postdexamethasone β-endorphin determinations at 4:00 PM. The cortisol data from this group followed the same pattern as in the first sample, and there was a significant relationship between HRSD score and degree of β-endorphin nonsuppression as well. These results suggest that severity of depression is one of the determinants of dysregulation at both adrenal and pituitary levels of the HPA axis, accounting for 10%–20% of the observed variance.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Brown WA
        • Shuey I
        Response to dexamethasone and subtype of depression.
        Arch Gen Psychiatry. 1980; 37: 747-751
        • Brown WA
        • Daamen M
        • D'Agostino C
        • Dockery EL
        • Fournier PA
        • Parsells AH
        Cortisol level response to 1- and 2-mg doses of dexamethasone.
        Am J Psychiatry. 1983; 140: 609-611
        • Brown WA
        • Keitner G
        • Quails B
        • Haier R
        The Dexamethasone Suppression Test and pituitary-adrenocortical function.
        Arch Gen Psychiatry. 1985; 42: 121-123
        • Cahill CA
        • Matthews JD
        • Akil H
        Human plasma β-endorphin-like peptides: A rapid, high recovery extraction technique and validation of radioimmunoassay.
        J Clin Endocrinol Metab. 1983; 56: 992-997
        • Carroll BJ
        • Feinberg M
        • Greden JF
        • Tarika J
        • Albala AH
        • Haskett RF
        • James NMcI
        • Kronfol Z
        • Lohr N
        • Steiner M
        • de Vigne JP
        • Young EA
        A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.
        Arch Gen Psychiatry. 1981; 38: 15-22
        • Charles G
        • Vandewalle J
        • Meunier JC
        • Wilmotte J
        • Noel G
        • Fossoul C
        • Mardens Y
        • Mendlewicz J
        Plasma and urinary cortisol levels after dexamethasone in affective disorders.
        J Affect Dis. 1981; 3: 397-406
        • Chrousos GP
        • Schulte HM
        • Oldfield EH
        • Loriaux DL
        • Cutler GB
        • Kellner CH
        • Gold PW
        Corticotropin releasing factor: Basic and clinical studies.
        Psychopharmacol Bull. 1983; 19: 416-421
        • Davis KL
        • Davis BM
        • Mathe AA
        • Mohs RC
        • Rothpearl AB
        • Levy MI
        • Gorman LK
        • Berger P
        Age and the Dexamethasone Suppression Test in depression.
        Am J Psychiatry. 1984; 141: 872-874
        • Demers CM
        • Derck DD
        Comparison of competitive protein binding analysis and radioim-munoassay for the determination of cortisol in serum and urine.
        Clin Biochem. 1977; 10: 104-108
        • Dilsaver SC
        • Greden JF
        Effects of antidepressant withdrawal on the Dexamethasone Suppression Test.
        Psychiatry Res. 1985; 14: 111-122
        • Gold PW
        • Chrousos G
        • Kellner C
        • Post R
        • Roy A
        • Augerinos P
        • Schulte H
        • Oldfield E
        • Loriaux DL
        Psychiatric implications of basic and clinical studies with corticotropin releasing factor.
        Am J Psychiatry. 1984; 141: 619-627
        • Goldberg IK
        Dexamethasone Suppression Test as indicator of safe withdrawal of antidepressant therapy.
        Lancet. 1980; i: 376
        • Hamilton M
        A rating scale for depression.
        J Neurol Neurosurg Psychiatry. 1960; 23: 56-62
        • Holsboer F
        • Gerken A
        • Stalla GK
        • Muller OA
        ACTH, cortisol, and corticosterone output after ovine corticotropin releasing factor challenge during depression and after recovery.
        Biol Psychiatry. 1985; 20: 276-286
        • Kalin NK
        • Weiler SJ
        • Shelton SE
        Plasma ACTH and cortisol concentrations before and after dexamethasone.
        Psychiatry Res. 1982; 7: 87-92
        • Keitner GI
        • Brown WA
        • Quails CB
        • Haier RJ
        • Barnes KT
        Results of the Dexamethasone Suppression Test in psychiatric patients with and without weight loss.
        Am J Psychiatry. 1985; 142: 246-248
        • Kroll P
        • Palmer C
        • Greden JF
        The Dexamethasone Suppression Test in patients with alcoholism.
        Biol Psychiatry. 1983; 18: 441-450
        • Krishnan KRR
        • France RD
        • Pelton S
        • McCann UD
        • Manepalli AN
        • Davidson JRT
        What does the Dexamethasone Suppression Test identify?.
        Biol Psychiatry. 1985; 20: 957-964
        • Krishnan KRR
        • France RD
        • Snipes MT
        • Pelton S
        Weight change and the Dexamethasone Suppression Test.
        Biol Psychiatry. 1985; 20: 1018-1022
        • Kumar A
        • Alcser K
        • Grunhaus L
        • Greden JF
        Relationships of the Dexamethasone Suppression Test to clinical severity and degree of melancholia.
        Biol Psychiatry. 1986; 21: 436-444
        • Lenox RH
        • Peyser JM
        • Rothschild B
        • Shipley J
        • Weaver L
        Failure to normalize the Dexamethasone Suppression Test: Association with length of illness.
        Biol Psychiatry. 1985; 20: 333-337
        • Lewis DA
        • Pfohl B
        • Schlechte J
        • Coryell W
        Influence of age on the cortisol response to dexamethasone.
        Psychiatry Res. 1984; 13: 213-220
        • Matthews J
        • Akil H
        • Greden J
        • Watson SJ
        Plasma measures of beta-endorphin-like immunoreactivity in depressives and other psychiatric subjects.
        Life Sci. 1982; 31: 1867-1870
        • Matthews J
        • Akil H
        • Greden J
        • Charney D
        • Weinberg V
        • Rosenbaum A
        • Watson SJ
        Beta-endorphin/beta-lipotropin-like immunoreactivity in endogenous depression: Effect of dexamethasone.
        Arch Gen Psychiatry. 1986; 43: 374-381
        • Meltzer HY
        • Fang VS
        Cortisol determination and the Dexamethasone Suppression Test.
        Arch Gen Psychiatry. 1983; 40: 501-505
        • Murphy BE
        Some studies of the protein-binding of steroids and their application to the routine micro- and ultra-micro measurement of various steroids in body fluids by competitive protein-binding radioassay.
        J Clin Endocrinol Metab. 1967; 27: 973-990
        • Nasr SJ
        • Gibbons RD
        Depressive symptoms associated with dexamethasone resistance.
        Psychiatry Res. 1983; 10: 183-189
        • Nasr SJ
        • Pandey G
        • Altman EG
        • Gibbons R
        • Gaviria FM
        • Davis JM
        Symptom profile of patients with positive DST: A pilot study.
        Biol Psychiatry. 1983; 18: 571-574
        • Nasr SJ
        • Rodgers C
        • Pandey G
        • Altman EG
        • Gaviria FM
        • Davis JM
        ACTH and the Dexamethasone Suppression Test in depression.
        Biol Psychiatry. 1983; 18: 1069-1073
        • Oxenkrug GF
        • Pomara N
        • McIntyre IM
        • Branconnier RJ
        • Stanely M
        • Gershon S
        Aging and cortisol resistance to suppression by dexamethasone: A positive correlation.
        Psychiatry Res. 1983; 10: 125-130
        • Pfohl B
        • Sherman B
        • Schlechte J
        • Stone R
        Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
        Arch Gen Psychiatry. 1985; 42: 897-903
        • Reus VI
        Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms.
        Biol Psychiatry. 1982; 17: 317-326
        • Rudorfer MV
        • Hwa H-G
        • Clayton PJ
        Dexamethasone Suppression Test in primary depression: Significance of family history and psychosis.
        Biol Psychiatry. 1982; 17: 41-48
        • Sangal R
        • Correa EI
        • DePaulo JR
        Depression and anxiety inventories, and the Dexamethasone Suppression Test.
        Biol Psychiatry. 1984; 19: 1207-1213
        • Sherman BM
        • Pfohl B
        Rhythm-related changes in pituitary-adrenal function in depression.
        J Affect Dis. 1985; 9: 55-64
        • Spitzer RL
        • Endicott J
        Schedule for Affective Disorders and Schizophrenia.
        Biometrics Research Division, New York State Psychiatric Institute, New York1975
        • Spitzer RL
        • Endicott J
        • Robins E
        Research Diagnostic Criteria (RDC).
        Biometrics Research Division, New York State Psychiatric Institute, New York1977
        • Yerevanian BI
        • Privitera MR
        • Milanese E
        • Sagi EA
        • Russotto JC
        The Dexamethasone Suppression Test during recurrent major depressive episodes.
        Biol Psychiatry. 1984; 19: 407-412
        • Zisook S
        • Janowsky DS
        • Overall JE
        • Risch SC
        The Dexamethasone Suppression Test and unipolar/bipolar distinctions.
        J Clin Psychiatry. 1985; 46: 461-465